Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer

IMPORTANCE: Combining conventional chemotherapy with targeted therapy has been proposed to improve the pathologic complete response (pCR) rate in patients with inflammatory breast cancer (IBC). Epidermal growth factor receptor (EGFR) expression is an independent predictor of low overall survival in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Oncol
Main Authors: Matsuda, Naoko, Wang, Xiaoping, Lim, Bora, Krishnamurthy, Savitri, Alvarez, Ricardo H., Willey, Jie S., Parker, Charla A., Song, Juhee, Shen, Yu, Hu, Jianhua, Wu, Wenhui, Li, Nan, Babiera, Gildy V., Murray, James L., Arun, Banu K., Brewster, Abenaa M., Reuben, James M., Stauder, Michael C., Barnett, Chad M., Woodward, Wendy A., Le-Petross, H. T. Carisa, Lucci, Anthony, DeSnyder, Sarah M., Tripathy, Debu, Valero, Vicente, Ueno, Naoto T.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2018
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143003/
https://ncbi.nlm.nih.gov/pubmed/29879283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.1436
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker